Patricia Font
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Journal: Cytometry. Part B, Clinical cytometry
Published: September 29, 2021
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.
Journal: Cytometry. Part B, Clinical cytometry
Published: July 09, 2021
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.
Journal: Cytometry. Part B, Clinical cytometry
Published: July 01, 2021
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: January 15, 2021
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 27, 2020
Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Journal: Molecular oncology
Published: October 18, 2020
Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?
Journal: Cytometry. Part B, Clinical cytometry
Published: March 05, 2017
Last Updated: 09/26/2026